Biomarkers and Therapeutical Targets for Prion Diseases
Confronta 1 prezzo
| Negozio | Disponibilità | Spedizione | Prezzo | Action |
|---|---|---|---|---|
 Springer Nature link.springer.com Miglior prezzo Disponibile | Disponibile | Gratuita | CHF 212.50 | Vai → Vai al negozio → |
Storico prezzi — prezzo più basso
Prezzo giornaliero più basso tra tutti i negozi · media del periodo: CHF 212.50
This book explores the intricate landscape of prion diseases, exploring the various methodologies for detecting human and animal prions, emphasizing both current techniques and those under development, as well as emerging techniques and methodologies for biomarker detection in prion diseases, paving the way for improved diagnostic and therapeutic approaches. The rational development of theranostic small molecules for prion diseases is also included, shedding light on potential treatment. It examines the utility of prion disease diagnostic markers in pre-symptomatic disease stages, offering insights into early detection strategies. Pharmacological approaches in prion diseases are explored, along with the potential of Lab-on-Chip platforms for monitoring prion and "prion-like" amyloid assembly and behavior. The role of reactive microglia and astrocytes as therapeutic targets is investigated, highlighting novel avenues for intervention. Furthermore, the book addresses biological fluid biomarkers in human prion diseases, paying special attention to biosafety considerations. Human genetic evidence is analyzed to identify new targets in prion diseases, discussing both opportunities and challenges. The utilization of RT-QuIC analysis of peripheral tissues and PMCA applications in prion disease diagnosis is examined, along with the extension of seed amplification assays for the clinical diagnosis of neurodegenerative disorders beyond prion pathologies. Overall, the book provides a comprehensive overview of biomarkers and therapeutic targets in prion diseases, encapsulating both current knowledge and emerging trends in the field. Chapter 10 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
Comparano confronta i prezzi di Biomarkers and Therapeutical Targets for Prion Diseases in 1 negozio online. Il miglior prezzo di oggi è CHF 212.50. I prezzi vengono aggiornati più volte al giorno; il prezzo finale è confermato nel negozio.
Prodotti simili
Altro in Libri →
Altro di Springer
Machine Learning and Knowledge Discovery in Databases. Research Track and Applied Data Science Track
Springer · Libri
da CHF 97.00
Vedi offerta
Leveraging Applications of Formal Methods, Verification and Validation. Scalable Verification and Validation of Concurrent and Distributed Systems
Springer · Libri
da CHF 47.18
Vedi offerta
Leveraging Applications of Formal Methods, Verification and Validation. X-by-Construction Meets Intersymbolic AI
Springer · Libri
da CHF 47.18
Vedi offerta
Information and Communications Security
Springer · Libri
da CHF 47.00
Vedi offerta